Medical economics

Pfizer poised to buy Metsera in $10 bn deal after bidding war

Pfizer was poised to seal a takeover of Metsera on Saturday after its improved offer won over the biotechnology startup's board and Danish challenger Novo Nordisk called a halt to a back-and-forth bidding war.

page 2 from 40